PTC Therapeutics to Participate at Upcoming Investor Conferences Feb 23, 2026 08:00AM
PTC Therapeutics (PTCT) PT Raised to $56 at TD Cowen Aug 8, 2025 08:17AM
PTC Therapeutics to Participate in Upcoming Investor Conferences Feb 20, 2025 08:00AM
PTC Therapeutics (PTCT) PT Raised to $60 at TD Cowen Following FDA Acceptance and Priority Review for Vatiquinone NDA Feb 19, 2025 10:31AM
PTC Therapeutics (PTCT) PT Raised to $50 at TD Cowen Jan 29, 2025 07:09AM


Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Oct 8, 2024 11:28AM TD Cowen Reiterates Hold Rating on PTC Therapeutics (PTCT)
Sep 5, 2024 01:58PM TD Cowen Reiterates Hold Rating on PTC Therapeutics (PTCT)
Aug 9, 2024 02:10PM PTC Therapeutics (PTCT) PT Raised to $33 at TD Cowen
Feb 27, 2024 05:20PM PTC Therapeutics to Participate at Upcoming Investor Conferences
Feb 21, 2023 08:00AM PTC Therapeutics to Participate at Upcoming Investor Conferences
Jun 21, 2022 04:12PM PTC Therapeutics (PTCT) PT Lowered to $45 at Cowen
Feb 23, 2022 08:00AM PTC Therapeutics to Participate at Upcoming Investor Conferences
Feb 23, 2022 05:34AM Cowen Reiterates PTC Therapeutics (PTCT) at Market Perform, Upcoming Quarters Will Determine Company's Trajectory
Feb 16, 2021 08:00AM PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences
Jan 11, 2021 11:54AM PTC Therapeutics (PTCT) PT Raised to $55 at Cowen
Jul 20, 2020 11:19AM Cowen Sees 'Mixed' Response in PTC Therapeutics (PTCT) After Royal Pharma's Risdiplam Deal
Feb 25, 2020 04:30PM PTC Therapeutics to Participate at Upcoming Investor Conferences
Mar 4, 2019 04:30PM PTC Therapeutics to Participate at Upcoming Investor Conferences
Mar 6, 2018 04:01PM PTC Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Mar 1, 2018 08:00AM PTC Therapeutics To Participate At Upcoming Investor Conferences
Oct 9, 2017 09:29AM Pre-Open Movers 10/09: (CLNT) (TROV) (GEVO) Higher; (XXII) (KTWO) (PTCT) Lower (more...)
Nov 11, 2016 09:29AM Pre-Open Stock Movers 11/11: (PTCT) (NVDA) (TTD) Higher; (PLAB) (JCP) (DDS) Lower (more...)
Mar 1, 2016 07:27AM Cowen Downgrades PTC Therapeutics (PTCT) to Market Perform
Feb 29, 2016 04:01PM PTC Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
Nov 10, 2015 09:34AM PTC Therapeutics (PTCT) Bullish Stance Reiterated at Cowen on Strong Translarna Sales Growth
Aug 25, 2015 10:32AM Notable Analyst Rating Changes 8/25: (AAPL) (BAC) (RF) Upgraded; (BOKF) (SUNE) (GAS) Downgraded
Jul 29, 2015 02:50PM Trading Radar for 7/30: P&G (PG), ConocoPhillips (COP), LinkedIn (LNKD), Expedia (EXPE), Electronic Arts (EA), Nokia (NOK) Report
Apr 16, 2015 10:56AM Notable Analyst Rating Changes 4/16: (COH) (INTC) (LOW) Upgraded; (AGCO) (NOK) (TRQ) Downgraded
Apr 16, 2015 09:47AM UPDATE: Cowen Upgrades PTC Therapeutics (PTCT) to Outperform
Oct 10, 2014 06:42AM PTC Therapeutics (PTCT) Prices 3M Common Offering at $36.25/Share
Oct 8, 2014 04:25PM PTC Therapeutics (PTCT) Announces 3M Common Stock Offering
Oct 6, 2014 07:14AM Cowen Downgrades PTC Therapeutics (PTCT) to Market Perform
Jul 26, 2013 08:38AM Cowen Starts PTC Therapeutics (PTCT) at Outperform
Jun 20, 2013 10:48AM PTC Therapeutics (PTCT) IPO Opens Higher
Jun 20, 2013 06:07AM PTC Therapeutics (PTCT) Prices 8.37M IPO at $15/Share
May 17, 2013 06:51AM PTC Therapeutics (PCTC) Files $85M IPO